Seth Klarman portfolio · Q2 2019
The Baupost Group, L.L.C. · CIK 0001061768 ·13F filings on SEC EDGAR
In Q2 2019, The Baupost Group, L.L.C. reported 32 positions worth $11B. Its largest holding was G5480U120 at 10.1% of the portfolio, and the top 10 made up 70%. Its largest new position was XPO ($86.7M), and it sold out of CELG.
- NEW 1
- ADD 8
- REDUCE 9
- EXIT 4
Portfolio map
Each box is a position sized by its value. Color shows the change in shares from the previous quarter.
Portfolio history
Q2 2013 to Q2 2019, 25 quarters
Weight of the largest holdings
The 7 holdings with the highest weight in any quarter shown, stacked with all others to 100%.
Holding timeline
Shade shows the weight in each quarter. A blank cell means the holding was not reported that quarter.
Holdings
Click a holding to see its price chart with the quarters the investor bought or sold.
| Name | Weight | Avg. cost (est.) | Latest price | Gain/loss | Value |
|---|---|---|---|---|---|
G5480U120 LIBERTY GLOBAL PLC | 10.07% | $23.77 | $18.56 | -21.9% | $778.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
VSAT VIASAT INC | 10.05% | $70.34* | $70.38 | +0.1% | $966.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
FOXA FOX CORP - CLASS A | 9.06% | $36.71 | $62.65 | +70.7% | $1.7B |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
EBAY EBAY INC | 8.63% | $30.64 | $106.05 | +246.2% | $2.6B |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
LNG CHENIERE ENERGY INC | 6.61% | $42.98 | $269.03 | +526.0% | $2.9B |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
AGN ALLERGAN UNLTD CO | 5.58% | $206.17 | $177.10 | -14.1% | $651.6M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
BMY BRISTOL-MYERS SQUIBB CO | 5.34% | $46.08 | $62.40 | +35.4% | $811.2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
QRVO QORVO INC | 5.23% | $67.34 | $114.48 | +70.0% | $993.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
PCG P G & E CORP | 5.08% | $35.24 | $18.38 | -47.9% | $450.2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
124857202 CBS CORP NEW | 4.52% | $46.91 | $40.37 | -13.9% | $403.7M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
MCK MCKESSON CORP | 3.16% | $135.75 | $853.81 | +529.0% | $2.2B |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
SYF SYNCHRONY FINANCIAL | 2.91% | $29.47 | $70.97 | +140.8% | $657.2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
| 2.68% | — | — | — | $295.5M | |
19626G108 COLONY CAP INC NEW | 2.25% | $6.25 | $6.48 | +3.7% | $322M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
UNVR UNIVAR SOLUTIONS LLC | 1.90% | $20.15 | $35.84 | +77.9% | $340.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
FOX FOX CORP - CLASS B | 1.88% | $35.88 | $56.30 | +56.9% | $319.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
G5480U104 LIBERTY GLOBAL PLC | 1.82% | $28.28 | $17.77 | -37.2% | $132.2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
COR CENCORA INC | 1.71% | $88.34 | $300.28 | +239.9% | $664.9M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
TAK TAKEDA PHARMACEUTIC-SP ADR | 1.51% | $20.37 | $18.19 | -10.7% | $171.7M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
AR ANTERO RESOURCES CORP | 1.43% | $20.74 | $33.39 | +61.0% | $954.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
TBPH THERAVANCE BIOPHARMA INC | 1.38% | $30.35 | $16.23 | -46.5% | $151.1M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
NXST NEXSTAR MEDIA GROUP INC | 1.28% | $86.06 | $161.57 | +87.7% | $225.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
046513107 ATARA BIOTHERAPEUTICS INC | 1.27% | — | $1.48 | — | $10.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
AKBA AKEBIA THERAPEUTICS INC | 1.07% | $5.53 | $1.14 | -79.4% | $27.9M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
89374L104 TRANSLATE BIO INC | 0.99% | $11.14 | $41.19 | +269.7% | $364.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
XPO XPO INC | 0.78% | $57.81 | $175.98 | +204.4% | $264M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
VRTV VERITIV CORP | 0.63% | $43.60 | $168.90 | +287.4% | $602M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
TMQ TRILOGY METALS INC | 0.36% | $0.87 | $2.10 | +141.0% | $28.6M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
829226109 SINCLAIR BROADCAST GROUP INC | 0.27% | $31.61 | $17.16 | -45.7% | $9.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
38341P102 GOSSAMER BIO INC | 0.25% | — | $0.16 | — | $208.6K |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
| 0.23% | — | — | — | $25.7M | |
PRTK PARATEK PHARMACEUTICALS INC | 0.09% | $29.51 | $2.21 | -92.5% | $5.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
Average cost is an estimate, not the investor's actual purchase price: every quarter the share count rose, the added shares are counted at that quarter-end's 13F price, and sales keep the average. Latest price is the most recent 13F quarter-end price (Sep 30, 2026), and value is shares × latest price. * Held since before Jun 30, 2013, when our collected history starts, so the average starts from that quarter's price.
Changes in shares
Change in shares held vs Mar 31, 2019, for the 20 largest positions that changed. Bars are capped at ±100%; the label shows the actual change.
Sold out this quarter
Held on Mar 31, 2019 and not reported for Q2 2019.
SEC filings for Q2 2019
- 13F-HR 0001567619-19-016587 · accepted Aug 13, 2019, 21:15 UTC